Delany-Moretlwe, SineadSmith, EmileeMyer, LandonAhmed, KhatijaNkala, BusiMaboa, ReboneGama, CynthiaSibiya, SydneySebe, ModulakgotlaBrumskine, WilliamBekker, Linda-GailNchabeleng, MaposhaneLombard, CarlGray, GlendaRees, Helen2016-01-282016-01-282014Delany-Moretlwe Sinead, Smith Emilee, Myer Landon, Ahmed Khatija, Nkala Busi, Maboa Rebone, Gama Cynthia, Sibiya Sydney, Sebe Modulakgotla, Brumskine William, Bekker Linda-Gail, Nchabeleng Maposhane, Lombard Carl, Gray Glenda, Rees Helen, and FACTS 001 Study Group. AIDS Research and Human Retroviruses. October 2014, 30(S1): A281-A282. doi:10.1089/aid.2014.5637.abstract.0889-222910.1089/aid.2014.5637.abstract.http://hdl.handle.net/11288/595092enTenofovir GelControlled TrialPreventionHIV-1HSV-2Randomised controlled trialFACTS 001: Characteristics of Participants Enrolled in a Phase III Randomised Controlled Trial of Tenofovir Gel for Prevention of HIV-1 and HSV-2Article1931-8405AIDS Research and Human Retroviruses